Jan-03 -
Gynecological Group
EORTC 55904 – Phase III study to evaluate platinum based chemotherapy as an adjuvant to surgery in early ovarian cancer patients.
EORTC study found that in patients diagnosed with early-stage ovarian cancer with non-optimal surgical staging, additional chemotherapy improves recurrence-free survival.
